Growth Metrics

TELA Bio (TELA) Current Leases (2022 - 2026)

TELA Bio's quarterly Current Leases came in at $527000.0 in Q1 2026, down 0.94% year-on-year from $532000.0 in Q1 2025, and up 0.57% quarter-over-quarter from $524000.0 in Q4 2025.

TELA Bio has reported Current Leases for 5 years, with the latest figure at $527000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 0.94% year-over-year to $527000.0; the trailing twelve-month figure through Mar 2026 stood at $527000.0 (down 0.94% YoY), and the FY2025 full-year result was $524000.0, up 4.8% from the prior year.
  • Current Leases for Q1 2026 stood at $527000.0, up from $524000.0 in the prior quarter.
  • The five-year high for Current Leases was $571000.0 in Q2 2024, with the low at $300000.0 in Q2 2022.
  • Average Current Leases over 5 years is $450588.2, with a median of $518000.0 recorded in 2025.
  • Year-over-year, Current Leases slipped 13.54% in 2023 and jumped 89.33% in 2024.
  • Tracing TELA's Current Leases over 5 years: stood at $340000.0 in 2022, then surged by 66.18% to $565000.0 in 2023, then declined by 11.5% to $500000.0 in 2024, then increased by 4.8% to $524000.0 in 2025, then climbed by 0.57% to $527000.0 in 2026.
  • The last three Current Leases figures came in at $527000.0 (Q1 2026), $524000.0 (Q4 2025), and $521000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 TELA Bio 13.26 Mn -26.28 Mn 12.52 Mn 527,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 527,000.00
Dec 31, 2025 524,000.00
Sep 30, 2025 521,000.00
Jun 30, 2025 518,000.00
Mar 31, 2025 532,000.00
Dec 31, 2024 500,000.00
Sep 30, 2024 559,000.00
Jun 30, 2024 571,000.00
Mar 31, 2024 568,000.00
Dec 31, 2023 565,000.00
Sep 30, 2023 345,000.00
Jun 30, 2023 343,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 340,000.00
Sep 30, 2022 300,000.00
Jun 30, 2022 300,000.00
Mar 31, 2022 347,000.00